Access Statistics for Margaret K. Kyle

Author contact details at EconPapers.

Working Paper	File Downloads				Abstract Views
Working Paper	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Competition and the Efficiency of Markets for Technology	0	1	1	90	0	1	4	116
Competition and the Efficiency of Markets for Technology	0	0	2	69	0	1	15	104
Did U.S. Bank Supervisors Get Tougher During the Credit Crunch? Did They Get Easier During the Banking Boom? Did It Matter to Bank Lending?	0	0	1	187	0	3	8	800
Did U.S. bank supervisors get tougher during the credit crunch? Did they get easier during the banking boom? Did it matter to bank lending?	0	0	1	137	4	5	12	506
Inefficiencies in technology transfer: theory and empirics	0	0	3	57	1	3	15	309
Inefficiencies in technology transfer: theory and empirics	0	0	0	9	1	5	13	64
Inefficiencies in the sale of ideas: theory and empirics	0	0	1	103	0	1	8	103
Intellectual Property Rights and Access to Innovation: Evidence from TRIPS	0	2	5	43	7	11	20	117
Investments in Pharmaceuticals Before and After TRIPS	0	0	2	86	0	2	11	227
Investments in Pharmaceuticals Before and After TRIPS	0	0	1	35	0	1	9	129
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs	0	2	4	42	0	2	8	38
Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research	0	0	0	123	6	7	11	349
Strategic Responses to Parallel Trade	0	0	0	129	2	3	9	372
The More We Die, The More We Sell? A Simple Test of the Home-Market Effect	0	0	7	20	4	5	23	65
Total Working Papers	0	5	28	1,130	25	50	166	3,299

Journal Article	File Downloads				Abstract Views
Journal Article	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Deregulating Direct-to-Consumer Marketing of Prescription Drugs: Effects on Prescription and Over-the-Counter Product Sales	0	0	0	6	2	2	6	73
Does locale affect R&D productivity? the case of pharmaceuticals	0	0	0	23	0	0	2	86
Generic competition and market exclusivity periods in pharmaceuticals	0	0	3	144	1	1	14	365
Intellectual Property Protection and the Geography of Trade	0	1	4	22	3	8	23	89
Investments in Pharmaceuticals Before and After TRIPS	1	2	12	144	4	7	30	429
Pharmaceutical Price Controls and Entry Strategies	2	13	31	444	4	20	59	948
Strategic Responses to Parallel Trade	2	2	6	70	4	8	27	287
The role of firm characteristics in pharmaceutical product launches	0	1	1	14	6	9	12	64
Total Journal Articles	5	19	57	867	24	55	173	2,341

Chapter	File Downloads				Abstract Views
Chapter	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Did U.S. Bank Supervisors Get Tougher during the Credit Crunch? Did They Get Easier during the Banking Boom? Did It Matter to Bank Lending?	0	0	1	38	3	5	12	134
Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research	0	0	0	0	2	3	11	85
The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals	0	1	5	5	2	7	16	16
The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches	0	1	2	91	2	10	15	279
Total Chapters	0	2	8	134	9	25	54	514

Software Item	File Downloads				Abstract Views
Software Item	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
MATLAB/C code for GIG and BNLG common value auction specifications	2	6	13	1,640	7	15	59	5,570
Total Software Items	2	6	13	1,640	7	15	59	5,570

Authors with papers registered in the RePEc Author Service.

Authors with no registered papers

LogEc provides access and usage for services based on the RePEc data set.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2020-02-04